Webinar on Personalized Medicine | Radiation Response Biomarkers for Individualised Cancer Treatments
Meet Our Speakers
Dr. Christophe Badie
Cancer Mechanisms and Biomarkers Group, UK Health Security Agency,
Harwell Campus, Oxfordshire, UK;
I am biologist who carried out a PhD in Radiobiology-Radiopathology. I worked on inter-individual radiation sensitivity and DSB repair. I identified the first radiotherapy patient whose radiation toxicity was due to a defect in DNA DSB repair which was thought to be almost incompatible with survival at the time; it was found later that the patient had a mutation in ligase IV. we are trying to better understand the mechanisms by which acute or protracted ionising radiation exposure either of natural or medical origin interacts and affects cells and individuals. I also work on identifying and validating new biomarkers of radiation exposure, susceptibility and toxicity and in cancer genomics to identify mutational signatures of ionizing radiation in second malignancies. Since 2005, I am leading the Cancer Mechanisms and Biomarkers group at UKHSA.
Sponsors and Partners
Organizer
On Wednesday 15 June 2022, MDPI and the Journal JPM organized the first webinar on Personalized Medicine, entitled “Radiation Response Biomarkers for Individualised Cancer Treatments”.
The introduction was held by the Chair of the webinar, Dr. Christophe Badie, Group Leader of Cancer Mechanisms and Biomarkers at the UK Health Security Agency. His work focuses on identifying and validating new biomarkers of radiation exposure, susceptibility and toxicity and in cancer genomics to identify mutational signatures of ionizing radiation in second malignancies.
The first speaker of the webinar was Dr. Elisa Placidi, Medical Physicist at the "Fondazione Policlinico Gemelli" in Rome. Her current main area of interest is treatment planning for External Beams and Interventional Radiotherapy, for a variety of brachytherapy treatments: gynecological, head and neck, skin, sarcomas, esophagus, prostate (HDR), interstitial anus. Her presentation was titled “Personalized Medicine in Brachytherapy”.
The second speaker of the session was Prof. Dr. Susan M. Bailey, with a presentation titled “TWINS & TELOMERES - In SPACE!”. Dr. Bailey is a Professor and Radiation Cancer Biologist in the Department of Environmental & Radiological Health Sciences at Colorado State University. Part of her current research program includes being one of 10 investigations selected by NASA for the TWINS Study, an integrated effort to launch human space life science research into a new era of molecular and "omics" based studies.
The presentations were followed by a Q&A and a discussion, moderated by the Chair. The webinar was offered via Zoom and required registration to attend. The full recording can be found here on Sciforum website. In order to stay updated on the next webinars on JPM, be sure to sign up for our newsletter by clicking on “Subscribe” at the top of the page.